International Dialogue on Sustainable Health Care

Baden-Baden, Germany / Florence, Italy, September 13, 2012 - Heel sponsors the 5th European Congress for Integrative Medicine in Florence, Italy / Presentation on Allergies

This year’s European Congress for Integrative Medicine (ECIM) will be held from September 20 to 22 in Florence, Italy. Here, more than 500 researchers, physicians and healthcare practitioners will be discussing experiences and the latest scientific research made in the field of integrative medical therapies of acute and chronic diseases.

The ECIM is one of the main major international events for researchers and medical doctors to discuss the efficacy of complementary medical treatments and their integration with conventional medicine – in daily practice and within the National Health Services in Europe. It examines developments in Oncology, Pediatrics and Veterinary Medicine and treatments of chronic pain and eating disorders, among others.

The presentations are held by leading experts from many European countries as well as Australia, Korea, China, India, Bangladesh, Israel, Saudi Arabia, Brazil and the USA. Among these: Dr. David Lescheid, Global Bioregulatory Medicine Manager at Heel. He will be presenting on “Getting to the root of the problem: Epithelial barrier dysfunction and its relation to the treatment of atopic and allergic diseases” on September 22.

Dr. Lescheid will be presenting current scientific knowledge demonstrating that there are multiple contributing factors to the development of allergic and atopic diseases, including the epithelial barrier dysfunction. A more comprehensive understanding of the underlying pathophysiology of allergies supports the use of multicomponent medications with multiple targets. A treatment strategy that focuses on treating the cause of these diseases should provide more long term relief of symptoms.

As this year’s ECIM, the European Society of Integrative Medicine (ESIM) will also be announcing the winners of a new international prize. The “Excellence in Integrative Medicine Research Award” recognizes innovative and excellent scientific projects in the field of integrative medicine. This includes the cooperation of conventional and complementary medicine as well as its bioregulatory aspects.

To qualify for this award, nominators must submit a scientific manuscript recently accepted for publication in a peer-reviewed journal. 43 papers have now been reviewed by an independent jury of international experts in Integrative Medicine headed by Prof. Dr. Stefan Willich, Director of the Institute for Social Medicine, Epidemiology and Health Economics of the Charité in Berlin, Germany. The prize rewards both basic and clinical research with 10,000 Euro each and is supported by Heel.

Dr. David Lescheid, Global Bioregulatory Medicine Manager at Heel, will be presenting at the ECIM on “Getting to the root of the problem: Epithelial barrier dysfunction and its relation to the treatment of atopic and allergic diseases”.
Dr. David Lescheid, Global Bioregulatory Medicine Manager at Heel, will be presenting at the ECIM on “Getting to the root of the problem: Epithelial barrier dysfunction and its relation to the treatment of atopic and allergic diseases”. Source Image: Heel
Dr. David Lescheid, Global Bioregulatory Medicine Manager at Heel, will be presenting at the ECIM on “Getting to the root of the problem: Epithelial barrier dysfunction and its relation to the treatment of atopic and allergic diseases”.
Dr. David Lescheid, Global Bioregulatory Medicine Manager at Heel, will be presenting at the ECIM on “Getting to the root of the problem: Epithelial barrier dysfunction and its relation to the treatment of atopic and allergic diseases”. Source Image: Heel

Downloads

Share this page